E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors.
CDH1
E-cadherin
HDAC inhibitors
HDGC
synthetic lethality
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Dec 2021
30 Dec 2021
Historique:
received:
04
12
2021
revised:
21
12
2021
accepted:
28
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
12
1
2022
Statut:
epublish
Résumé
Inactivating germline mutations in the
Identifiants
pubmed: 35008338
pii: cancers14010175
doi: 10.3390/cancers14010175
pmc: PMC8749989
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Health Research Council of New Zealand
ID : 17/610
Organisme : No Stomach for Cancer (NSFC)
ID : charity
Références
Cold Spring Harb Perspect Biol. 2014 Apr 01;6(4):a018713
pubmed: 24691964
Exp Hematol. 2011 Oct;39(10):1007-1017.e1
pubmed: 21767511
Blood Cancer J. 2012 May;2(5):e69
pubmed: 22829971
Mol Cancer Ther. 2015 May;14(5):1213-23
pubmed: 25777964
J Pediatr Surg. 2013 Apr;48(4):e17-20
pubmed: 23583159
J Clin Oncol. 2013 Mar 1;31(7):868-75
pubmed: 23341533
eNeuro. 2019 Feb 15;6(1):
pubmed: 30783618
Ther Adv Med Oncol. 2020 Oct 31;12:1758835920967238
pubmed: 33193828
J Cell Biochem. 2005 Oct 1;96(2):293-304
pubmed: 16088937
Lancet Oncol. 2020 Aug;21(8):e386-e397
pubmed: 32758476
Oncol Lett. 2016 Apr;11(4):2635-2643
pubmed: 27073531
Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):
pubmed: 27599530
J Cancer Res Clin Oncol. 2016 Feb;142(2):379-87
pubmed: 26314218
Jpn J Cancer Res. 2001 Dec;92(12):1300-4
pubmed: 11749695
Hypertens Res. 2016 Oct;39(10):709-716
pubmed: 27278287
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6561-5
pubmed: 22493260
Ann Surg Oncol. 2010 Dec;17(12):3336-43
pubmed: 20585871
Nat Rev Drug Discov. 2020 Jan;19(1):23-38
pubmed: 31712683
Front Pharmacol. 2018 Dec 05;9:1421
pubmed: 30568591
Am J Surg Pathol. 2020 Sep;44(9):1204-1212
pubmed: 32520759
Bioessays. 2016 Nov;38(11):1102-1110
pubmed: 27717012
Gut. 2012 Mar;61(3):344-53
pubmed: 21865403
Gut. 2004 Jun;53(6):814-20
pubmed: 15138207
Mol Cell. 2002 Jan;9(1):45-57
pubmed: 11804585
J Biomol Screen. 2016 Jul;21(6):643-52
pubmed: 26858181
Cancer Sci. 2009 Jul;100(7):1151-7
pubmed: 19432899
Gastric Cancer. 2019 Mar;22(2):273-286
pubmed: 30066183
Life Sci. 2020 May 1;248:117469
pubmed: 32109485
Future Oncol. 2017 Jun;13(13):1137-1148
pubmed: 28326839
Nat Genet. 2014 Jun;46(6):583-7
pubmed: 24816255
Cancer. 2017 Dec 15;123(24):4851-4859
pubmed: 28841236
Cancers (Basel). 2019 Sep 13;11(9):
pubmed: 31540244
Nat Rev Cancer. 2018 Jul;18(7):407-418
pubmed: 29692415
Front Oncol. 2018 Mar 29;8:92
pubmed: 29651407
J Med Chem. 2021 Dec 23;64(24):18114-18142
pubmed: 34878770
Biomed Pharmacother. 2021 Jun;138:111485
pubmed: 33740521
Expert Opin Ther Targets. 2013 Oct;17(10):1187-201
pubmed: 23957294
Biomedicines. 2020 Jan 30;8(2):
pubmed: 32019149
Methods Mol Biol. 2002;180:175-204
pubmed: 11873650
Pharmaceuticals (Basel). 2010 Aug 26;3(9):2751-2767
pubmed: 27713375
Cell Death Differ. 2019 Jan;26(2):199-212
pubmed: 30538286
Curr Top Med Chem. 2016;16(7):714-31
pubmed: 26303421
Cancers (Basel). 2019 Jan 27;11(2):
pubmed: 30691229
Cell Commun Adhes. 2013 Dec;20(6):189-99
pubmed: 24205986
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):5931-5937
pubmed: 32127478
J Cell Biol. 2001 Sep 17;154(6):1185-96
pubmed: 11564756
Nat Genet. 2000 Sep;26(1):16-7
pubmed: 10973239
BMC Cancer. 2015 Dec 16;15:954
pubmed: 26674321
J Cell Mol Med. 2020 Jun;24(11):5930-5936
pubmed: 32301282
Biomed Res Int. 2014;2014:637308
pubmed: 25184143
Int J Mol Sci. 2020 Jul 31;21(15):
pubmed: 32752096